School personnel information

写真b

TAKENAKA Satoshi


Organization 【 display / non-display

  • 2011.04.01 - 2011.05.31, Division of Medicine, Graduate School of Medicine, Specially Appointed Researcher

  • 2015.09.01 - 2015.09.30, Division of Medicine, Graduate School of Medicine, Assistant Professor

  • 2015.10.01 - 2019.08.15, Division of Medicine, Graduate School of Medicine, Assistant Professor

  • 2019.08.16 - , Graduate School of Medicine, Assistant Professor

 

Academic Papers 【 display / non-display

  • Silent subperiosteal iliac hematoma with bone radiolucency in adolescent male athletes., Takenaka S, Hamada KI, Tanaka H, Outani H, Naka N, Yoshikawa H, Journal of orthopaedics,17 198-202, 2020.01, Other

  • Eribulin suppresses clear cell sarcoma growth by inhibiting cell proliferation and inducing melanocytic differentiation both directly and via vascular remodeling., Nakai S, Tamiya H, Imura Y, Nakai T, Yasuda N, Wakamatsu T, Tanaka T, Outani H, Takenaka S, Hamada K, Myoui A, Araki N, Ueda T, Yoshikawa H, Naka N, Molecular cancer therapeutics, 2019.12, Other

  • Establishment of a novel human CIC-DUX<sub>4</sub> sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungs., Nakai S, Yamada S, Outani H, Nakai T, Yasuda N, Mae H, Imura Y, Wakamatsu T, Tamiya H, Tanaka T, Hamada K, Tani A, Myoui A, Araki N, Ueda T, Yoshikawa H, Takenaka S, Naka N, Scientific reports,9(1) 15812, 2019.11, Other

  • Prognostic implication of adjuvant/neoadjuvant chemotherapy consisting of doxorubicin and ifosfamide in patients with extraskeletal osteosarcoma., Wakamatsu T, Kakunaga S, Takenaka S, Outani H, Hamada K, Imura Y, Hori Y, Naka N, Kudawara I, Yoshikawa H, Ueda T, International journal of clinical oncology,24(10) 1311-1319, 2019.10, Other

  • Favorable outcomes of localized synovial sarcoma patients with a high utilization rate of neoadjuvant and/or adjuvant chemotherapy., Outani H, Kakunaga S, Hamada K, Takenaka S, Imura Y, Nagata S, Tanaka T, Tamiya H, Oshima K, Naka N, Kudawara I, Araki N, Ueda T, Yoshikawa H, Molecular and clinical oncology,11(2) 151-156, 2019.08, Other

display all >>